Pentoxifylline therapy among preterm neonates< 1,500 g in reducing mortality from neonatal sepsis: a double-blind, randomized placebo-controlled trial
Background Pentoxifylline, a xanthine derivative, has raised new interest in neonatal research due to its immunomodulatory functions and its potential role in reducing mortality from …..... Read More